Business Context and Reporting Period
This Form 8-K is filed by Chavant Capital Acquisition Corp. (not Mobix Labs, Inc., which is the target of a proposed business combination) for the reporting date of July 18, 2023. The filing details the results of an Extraordinary General Meeting held to approve amendments to the Company's Articles of Association and updates regarding a proposed merger with Mobix Labs, Inc.
Key Financial Metrics and Voting Results
The filing does not provide standard financial statements (revenue, profit, cash flow) as it is a current report on corporate governance and transaction updates. Key quantitative data points include:
- Shareholder Participation: 2,672,996 ordinary shares (approx. 93.59% of voting shares) were present or represented by proxy.
- Redemptions: 77,130 ordinary shares were redeemed for a pro rata portion of the Trust Account.
- Trust Account Deposit: An initial deposit of $38,945.60 was made into the Trust Account to fund the extension (calculated at $0.05 per non-redeeming public share per month).
- Future Deposits: The Company expects to continue depositing $38,945.60 for each subsequent monthly period required to complete a business combination by the new deadline.
Material Changes and Corporate Actions
Shareholders approved two critical amendments effective immediately:
- Extension of Deadline: The date by which the Company must consummate an initial business combination was extended from July 22, 2023, to January 22, 2024.
- Removal of Redemption Limitations: The Company eliminated the limitation preventing redemptions that would cause net tangible assets to fall below $5,000,001 and the requirement to maintain at least $5,000,001 in net tangible assets to consummate a business combination.
Voting Results:
- Extension Amendment: 2,669,150 For; 3,846 Against; 0 Abstain.
- Redemption Limitation Amendment: 2,672,153 For; 843 Against; 0 Abstain.
Outlook, Risks, and Proposed Transaction
Proposed Transaction: The Company is pursuing a business combination with Mobix Labs, Inc. pursuant to an agreement dated November 15, 2022. A registration statement on Form S-4 has been filed with the SEC.
Management Commentary and Risks: The filing includes extensive forward-looking statements regarding the anticipated benefits of the transaction, Mobix Labs' technology, and growth plans. Key risks identified include:
- Failure to complete the transaction by the extended deadline or at all.
- Inability to satisfy minimum cash requirements following redemptions.
- Disruption to Mobix Labs' business operations and employee retention.
- Regulatory and geopolitical risks, including U.S./China trade tensions and 5G technology transitions.
- Failure to commercialize semiconductor products or achieve profitability.
- Volatility in the price of Chavant's securities.
Investor Verification Checklist
- Verify the final redemption count and the resulting cash balance in the Trust Account to ensure it meets the minimum cash requirement for the Mobix Labs merger.
- Review the definitive Proxy Statement/Prospectus (Form S-4) for detailed terms of the Mobix Labs business combination.
- Confirm the status of the PIPE (Private Investment in Public Equity) investment, as the filing notes the risk of inability to complete it.
- Monitor the Company's ability to maintain Nasdaq listing requirements following the removal of the $5,000,001 net tangible asset limitation.
- Assess the timeline for the final shareholder vote on the Mobix Labs transaction, which is separate from the extension vote reported here.